Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 0.0979 | 1 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.0979 | 1 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.0175 | 0.0727 | 0.5 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.0175 | 0.0727 | 0.5 |
Trypanosoma brucei | N-myristoyltransferase | 0.0175 | 0.0727 | 0.5 |
Mycobacterium ulcerans | naphthoate synthase | 0.0961 | 1 | 0.5 |
Schistosoma mansoni | N-myristoyltransferase | 0.0175 | 0.0727 | 1 |
Giardia lamblia | CDC72 | 0.0175 | 0.0727 | 0.5 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.0786 | 0.2345 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.0786 | 0.2345 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 0.0979 | 1 |
Mycobacterium tuberculosis | Naphthoate synthase MenB (dihydroxynaphthoic acid synthetase) (DHNA synthetase) | 0.0961 | 1 | 0.5 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0197 | 0.0979 | 1 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.0175 | 0.0727 | 0.5 |
Leishmania major | N-myristoyl transferase, putative | 0.0175 | 0.0727 | 0.5 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0175 | 0.0727 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0786 | 0.2345 |
Onchocerca volvulus | 0.0114 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0786 | 0.2345 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.0786 | 0.2345 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 0.0979 | 1 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.0175 | 0.0727 | 1 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.0175 | 0.0727 | 0.5 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.0786 | 0.2345 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.0175 | 0.0727 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (binding) | 14.1254 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.7279 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.